Maintaining protein homeostasis (proteostasis) is essential for organismal health, and several different signaling pathways have been shown to aid in maintaining proteostasis. Our lab has defined a novel proteostasis pathway by analyzing the common transcriptional response to diverse intracellular pathogens, which we named the Intracellular Pathogen Response (IPR). The IPR is controlled by the antagonistic paralogs
pals-22 and
pals-25, which serve as a genetic switch between increased pathogen resistance and thermotolerance, and normal development. Interestingly, the IPR can be activated not just by infection, but also by heat stress and proteasome inhibitors, indicating that the IPR plays a role in response to diverse proteotoxic stressors. The IPR involves transcriptional activation of ~80 genes, some of which are predicted to encode ubiquitin ligase components. One of the most highly induced IPR genes is
pals-5, which has no known biochemical function, but serves as a robust readout for the IPR activation. Using
pals-5::GFP reporters, we identified ZIP-1 as a positive regulator of the IPR in two reverse genetic screens. ZIP-1 contains a bZIP domain, and is classified as a transcription factor. Our qRT-PCR and smFISH studies demonstrate that ZIP-1 controls
pals-5 transcription early after IPR induction by the proteasome inhibitor bortezomib, although
pals-5 transcription late after IPR induction appears independent of ZIP-1. In addition, we found that ZIP-1 is required for transcription of the putative ubiquitin ligase component
skr-5, which promotes thermotolerance as part of the IPR. Moreover, we identified a set of IPR genes that are not regulated by ZIP-1. Taken together, our studies uncover three distinct types of IPR genes: a) completely ZIP-1-dependent, b) partially ZIP-1-dependent and c) ZIP-1-independent. Interestingly, we observed that loss-of-function mutations in
pals-22 and
zip-1 are synthetically lethal, indicating that there is a fine balance between these IPR regulators, which are important for normal development in the absence of external proteotoxic stressors. To further explore IPR regulation, we have also isolated several mutants with constitutively active IPR that are currently being characterized.